This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cytokinetics Inc (CYTK)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 20.22M 20.16M 14.91M 18.83M
Receivables 46.65M 5.00K 4.00K 14.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 131.13M 79.34M 76.43M 51.14M
Property, Plant & Equipment, Gross 21.96M 22.21M 24.28M 24.10M
Accumulated Depreciation & Depletion 20.33M 20.99M 23.29M 22.79M
Property, Plant & Equipment, Net 1.64M 1.22M 997.00K 1.31M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 200.00K 2.63M 127.00K 323.00K
Total Non-Current Assets 1.84M 3.85M 1.12M 1.63M
Liabilities & Shareholder Equity
Total Assets 132.97M 83.19M 77.55M 52.77M
Accounts Payable 1.36M 3.71M 2.15M 1.21M
Short Term Debt 0.00 0.00 0.00 152.00K
Other Current Liabilities 52.00K 0.00 0.00 0.00
Total Current Liabilities 23.86M 26.70M 7.10M 4.59M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 491.00K 542.00K 361.00K 3.00K
Other Non-Current Liabilities 16.56M 1.50M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 17.05M 2.04M 361.00K 3.00K
Total Liabilities 40.90M 28.75M 7.47M 4.60M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 92.06M 54.44M 70.08M 48.18M
Common Par 39.00K 31.00K 143.00K 75.00K
Additional Paid In Capital 589.27M 537.00M 518.80M 456.61M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -497.24M -482.60M -448.88M -408.51M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -4.00K 7.00K 18.00K 3.00K
Total Capitalization 92.06M 54.44M 70.08M 48.18M
Total Equity 92.06M 54.44M 70.08M 48.18M
Total Liabilities & Stock Equity 132.97M 83.19M 77.55M 52.77M
Total Common Shares Outstanding 38.66M 30.68M 23.74M 12.49M
Preferred Shares 4.00K 4.00K 23.03K 8.07K
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 35.71M 27.28M 18.11M 11.80M
Diluted Weighted Shares Outstanding 35.71M 27.28M 18.11M 11.80M
Number of Employees 92 85 70 79
Number of Part-Time Employees 0 0 0 0

CYTK Cytokinetics Inc

Chart of CYTK

Analysts Ratings for CYTK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

CYTK Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs